AEON Biopharma, Inc. - 8-K Filing
AEON Biopharma reduces milestone warrant exercise prices and expects $6.2 million in gross proceeds from immediate exercises. (Items: 1.01 Entry into a Material Definitive Agreement, 9.01 Financial Statements and Exhibits)